You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 20 No. 1, January 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (63)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum and Cerebrospinal Fluid Enzymes in Cerebrovascular Disease

Creatine Phosphokinase, Aldolase, and Lactic Dehydrogenase

Arthur H. Wolintz, MD; Lawrence D. Jacobs, MD; Nicholas Christoff, MD; Misu Solomon, PhD; Norman Chernik, MD

Arch Neurol. 1969;20(1):54-61.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE clinical significance of enzymology in neurological disorders is as yet uncertain. A number of enzymes have been studied both in serum and in cerebrospinal fluid (CSF). In general, these studies have been limited to a single enzyme and have not included a comparison of the serum and CSF activities of the same enzymes.1-12 Much more needs to be known about the levels of different enzymes in CSF, their relation with one another, and their relation to the serum levels of the same enzymes.

In the present study, we compare the CSF and serum activities of the enzymes creatine phosphokinase (CPK), lactic dehydrogenase (LDH), and aldolase (ALD) in a series of patients suffering from acute vascular disorders of the brain. These enzymes are well-known in clinical enzymology and have been studied to some extent in the CSF. CPK in particular is an attractive enzyme because it is found . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the departments of neurology (Drs. Jacobs, Christoff, and Chernik) and clinical pathology (Dr. Solomon), The Mount Sinai Services, City Hospital at Elmhurst and The Mount Sinai School of Medicine (Drs. Jacobs, Christoff, Chernik, and Solomon), New York, and the Department of Neurology, Maimonides Medical Center, Brooklyn (Dr. Wolintz).


Footnotes

Submitted for publication July 26, 1968; accepted Sept 6.

Reprint requests to Division of Neurology, Maimonides Medical Center, 4802 10th Ave, Brooklyn, New York 11219.

Read in part before the annual meeting of the American Neurological Association, Washington, DC, June 19, 1968.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.